“DeepDR Plus,” a deep learning system, accurately predicts diabetic retinopathy progression up to five years using fundus images, offering potential for personalized screening and management in diabetic patients.
Updated: Moderna partners with Blackstone on flu shots, nabbing up to $750M in R&D funding
Moderna announced Wednesday that it is teaming up with Blackstone for its influenza program. Under the collaboration, Blackstone will provide “up to $750 million,” according
March 28, 2024